Showing results (321-330 of 498) with videos related to
Sort By:
Pageof 50
Frontiers in Medicine|September 1, 2015
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary TumorsMagali Roche, Anne Wierinckx, Séverine Croze, et al.European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 25, 2008
Score predicting imminent delivery in pregnant women calling the emergency medical serviceFrédéric Berthier, Bernard Branger, Frédéric Lapostolle, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
The Diflunisal Trial: study accrual and drug toleranceJohn L Berk, Ole B Suhr, Yoshiki Sekijima, et al.Clinical Chemistry|January 10, 2009
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urineGiovanni Palladini, Paola Russo, Tiziana Bosoni, et al.Journal of Molecular Biology|April 9, 2008
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation propertiesGennaro Esposito, Stefano Ricagno, Alessandra Corazza, et al.Journal of Molecular Biology|October 21, 2023
Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformationLuca Broggini, Maria Monica Barzago, Valentina Speranzini, et al.Kidney International|January 22, 2015
Diagnosis of monoclonal gammopathy of renal significanceFrank Bridoux, Nelson Leung, Colin A Hutchison, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 10, 2025
Global patterns of amyloid typing: results of a survey by the International Society of Amyloidosis (ISA)Hironobu Naiki, Mona Johnson, Kaylee Walters, et al.American Journal of Hematology|January 28, 2023
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choiceVaishali Sanchorawala, Ashutosh D Wechalekar, Kihyun Kim, et al.Journal of the American Society of Nephrology : JASN|June 15, 2016
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CIISamih H Nasr, Surendra Dasari, Linda Hasadsri, et al.Pageof 50